• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

唐氏综合征中脑代谢的阿尔茨海默病模式检测。

Detection of an Alzheimer disease pattern of cerebral metabolism in Down syndrome.

作者信息

Azari N P, Pettigrew K D, Pietrini P, Horwitz B, Schapiro M B

机构信息

Laboratory of Neurosciences/NIA/NIH, Bethesda, Md 20892.

出版信息

Dementia. 1994 Mar-Apr;5(2):69-78. doi: 10.1159/000106700.

DOI:10.1159/000106700
PMID:8038869
Abstract

Correlational analysis of cerebral metabolic (rCMRglc) data obtained with positron emission tomography (PET) assesses group differences and has demonstrated reduced frontal-parietal rCMRglc interdependencies in Alzheimer's disease (AD). A multivariate analysis of rCMRglc data assesses individual differences. We recently identified discriminant functions, reflecting frontal-parietal rCMRglc interdependencies, that separated AD from control subjects. To test if the functions would identify an AD rCMRglc pattern in older Down syndrome (DS) adults with (DS DAT+) or without (DS DAT-) dementia, we applied the functions to longitudinal rCMRglc data in: young DS (n = 15), DS DAT- (n = 10), DS DAT+ (n = 4), and young controls (n = 15). All DS DAT+ and some of the later DS DAT- scans were classified as AD. The results provide additional validation of the functions and suggest their utility for the early detection of AD.

摘要

通过正电子发射断层扫描(PET)获得的脑代谢(rCMRglc)数据的相关性分析评估了组间差异,并已证明阿尔茨海默病(AD)患者额顶叶rCMRglc的相互依赖性降低。rCMRglc数据的多变量分析评估个体差异。我们最近确定了反映额顶叶rCMRglc相互依赖性的判别函数,这些函数可将AD患者与对照受试者区分开来。为了测试这些函数是否能识别患有(DS DAT+)或未患有(DS DAT-)痴呆症的老年唐氏综合征(DS)成年人的AD rCMRglc模式,我们将这些函数应用于以下纵向rCMRglc数据:年轻DS患者(n = 15)、DS DAT-患者(n = 10)、DS DAT+患者(n = 4)和年轻对照者(n = 15)。所有DS DAT+患者以及一些后期的DS DAT-扫描结果均被归类为AD。结果为这些函数提供了额外的验证,并表明它们在AD早期检测中的实用性。

相似文献

1
Detection of an Alzheimer disease pattern of cerebral metabolism in Down syndrome.唐氏综合征中脑代谢的阿尔茨海默病模式检测。
Dementia. 1994 Mar-Apr;5(2):69-78. doi: 10.1159/000106700.
2
Early detection of Alzheimer's disease: a statistical approach using positron emission tomographic data.阿尔茨海默病的早期检测:一种使用正电子发射断层扫描数据的统计方法。
J Cereb Blood Flow Metab. 1993 May;13(3):438-47. doi: 10.1038/jcbfm.1993.58.
3
Low glucose metabolism during brain stimulation in older Down's syndrome subjects at risk for Alzheimer's disease prior to dementia.在患阿尔茨海默病风险较高的老年唐氏综合征患者出现痴呆之前,大脑刺激期间葡萄糖代谢较低。
Am J Psychiatry. 1997 Aug;154(8):1063-9. doi: 10.1176/ajp.154.8.1063.
4
Regional cerebral glucose metabolism is normal in young adults with Down syndrome.唐氏综合征青年成人的局部脑葡萄糖代谢正常。
J Cereb Blood Flow Metab. 1990 Mar;10(2):199-206. doi: 10.1038/jcbfm.1990.35.
5
Temporal cortex hypermetabolism in Down syndrome prior to the onset of dementia.唐氏综合征患者在痴呆症发作前颞叶皮质代谢亢进。
Neurology. 2003 Dec 23;61(12):1673-9. doi: 10.1212/01.wnl.0000098935.36984.25.
6
[The comparison of the regional cerebral metabolism rate of glucose in Alzheimer's disease with mild cognitive impairment].[阿尔茨海默病伴轻度认知障碍患者局部脑葡萄糖代谢率的比较]
Zhonghua Yi Xue Za Zhi. 2002 Dec 10;82(23):1613-6.
7
Pattern of cerebral metabolic interactions in a subject with isolated amnesia at risk for Alzheimer's disease: a longitudinal evaluation.一名有患阿尔茨海默病风险的孤立性失忆症患者的脑代谢相互作用模式:纵向评估
Dementia. 1993 Mar-Apr;4(2):94-101. doi: 10.1159/000107349.
8
Comparison of positron emission tomography, cognition, and brain volume in Alzheimer's disease with and without severe abnormalities of white matter.阿尔茨海默病中有无严重白质异常情况下正电子发射断层扫描、认知及脑容量的比较
J Neurol Neurosurg Psychiatry. 1996 Feb;60(2):158-67. doi: 10.1136/jnnp.60.2.158.
9
Cerebral metabolic changes accompanying conversion of mild cognitive impairment into Alzheimer's disease: a PET follow-up study.轻度认知障碍转化为阿尔茨海默病时伴随的脑代谢变化:一项PET随访研究
Eur J Nucl Med Mol Imaging. 2003 Aug;30(8):1104-13. doi: 10.1007/s00259-003-1194-1. Epub 2003 May 23.
10
[Change of cerebral metabolism rate of glucose of cerebral white matter in Alzheimer's disease: a study with statistical parametric mapping software].阿尔茨海默病脑白质葡萄糖脑代谢率的变化:一项使用统计参数映射软件的研究
Zhonghua Yi Xue Za Zhi. 2007 Oct 23;87(39):2777-9.

引用本文的文献

1
Regional Brain Metabolism across the Alzheimer's Disease Continuum in Down Syndrome.唐氏综合征患者阿尔茨海默病连续病程中的区域脑代谢
Ann Neurol. 2025 Jul;98(1):163-173. doi: 10.1002/ana.27226. Epub 2025 Mar 14.
2
A Review of Functional Neuroimaging in People with Down Syndrome with and without Dementia.对患有和未患痴呆症的唐氏综合征患者的功能性神经影像学综述。
Dement Geriatr Cogn Dis Extra. 2021 Dec 27;11(3):324-332. doi: 10.1159/000520880. eCollection 2021 Sep-Dec.
3
Distribution of microglial phenotypes as a function of age and Alzheimer's disease neuropathology in the brains of people with Down syndrome.
唐氏综合征患者大脑中作为年龄和阿尔茨海默病神经病理学函数的小胶质细胞表型分布。
Alzheimers Dement (Amst). 2020 Oct 14;12(1):e12113. doi: 10.1002/dad2.12113. eCollection 2020.
4
Metabolic and Vascular Imaging Biomarkers in Down Syndrome Provide Unique Insights Into Brain Aging and Alzheimer Disease Pathogenesis.唐氏综合征中的代谢和血管成像生物标志物为脑老化和阿尔茨海默病发病机制提供了独特见解。
Front Aging Neurosci. 2018 Jun 21;10:191. doi: 10.3389/fnagi.2018.00191. eCollection 2018.
5
Dissociation of Down syndrome and Alzheimer's disease effects with imaging.通过影像学对唐氏综合征与阿尔茨海默病效应进行解离研究。
Alzheimers Dement (N Y). 2016 Jun;2(2):69-81. doi: 10.1016/j.trci.2016.02.004.
6
Florbetapir PET, FDG PET, and MRI in Down syndrome individuals with and without Alzheimer's dementia.在患有和未患阿尔茨海默病痴呆症的唐氏综合征个体中进行的氟代硼吡咯正电子发射断层扫描(Florbetapir PET)、氟脱氧葡萄糖正电子发射断层扫描(FDG PET)和磁共振成像(MRI)。
Alzheimers Dement. 2015 Aug;11(8):994-1004. doi: 10.1016/j.jalz.2015.01.006. Epub 2015 Apr 4.
7
Functional brain imaging to identify affected subjects genetically at risk for Alzheimer's disease.通过功能性脑成像来识别有患阿尔茨海默病遗传风险的受影响个体。
Proc Natl Acad Sci U S A. 2000 May 23;97(11):5696-8. doi: 10.1073/pnas.120178897.
8
Preclinical stages in subjects at risk for neurological disorders: can PET-FDG tell us more?神经系统疾病高危人群的临床前阶段:PET-FDG 能告诉我们更多信息吗?
J Neurol. 1995 Jan;242(2):112-4. doi: 10.1007/BF00887827.